Form 4: CareDx Director George Bickerstaff Exercises Stock Options
SEC Form 4 Filing
Director George Bickerstaff exercised stock options to acquire CareDx shares at prices of $5.85 and $5.49 on November 1, 2024.
Summary
- On November 1, 2024, George Bickerstaff, a director of CareDx, Inc., exercised stock options.
- He acquired 5,255 shares of common stock at a price of $5.85 per share.
- Additionally, he acquired 2,226 shares of common stock at a price of $5.49 per share.
- Following these transactions, Bickerstaff directly owns 123,027 shares of CareDx common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock option exercises.
Positives
- The exercise of stock options by a director could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future actions of key personnel.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder sentiment if viewed as a sign of confidence by the director.
Key Dates
| Date | Description |
|---|---|
| 06/17/2016 | Date the shares subject to the $5.85 option vested fully. |
| 11/08/2018 | Date the shares subject to the $5.49 option vested fully. |
| 11/01/2024 | Date of the stock option exercises. |
| 11/05/2024 | Date of the form filing. |
| 06/17/2025 | Expiration date of the $5.85 stock option. |
| 11/09/2024 | Expiration date of the $5.49 stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.